SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing intense volatility after the FDA released briefing documents questioning the effectiveness of its lead drug, deramiocel, ahead of an upcoming advisory committee meeting. Investors are actively debating the company's rebuttal, which alleges the FDA relied on obsolete statistical analysis plans, turning the July 29 AdCom into a critical binary event that has sparked a significant sell-off.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing intense selling pressure fueled by market skepticism over AI infrastructure financing, with investors debating whether the reported high demand is organic or driven by cyclical debt-backed deals. While some community members view the pullback as a tactical shakeout and a buying opportunity, others are concerned about rising competition from China and the sustainability of massive AI capital expenditures.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is experiencing heightened volatility and active community debate as investors parse the impact of analyst downgrades against a perceived valuation discount in the SaaS sector. Traders are closely monitoring the stock's ability to sustain recent technical breakouts while weighing broader concerns regarding AI disruption against the company's strong cash flow and potential leadership changes.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing high volatility as investors react to an arbitration ruling that dismissed the company's claims against 3D Medicines, despite the preservation of their licensing agreement. While community members debate whether this setback and the stock's recent price dip represent a buying opportunity or a deeper issue, the focus remains firmly on the anticipated top-line results from the REGAL Phase 3 trial and a potential buyout.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is gaining renewed interest as analysts and investors debate whether the recent sector-wide selloff in software has created an attractive valuation entry point for high-quality enterprise platforms. The community is actively discussing the stock's long-term potential as a workflow and data leader in the AI era, while navigating ongoing skepticism regarding near-term growth trajectories and broader software rotation trends.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a recent grant from the National Science Foundation and the company's transfer of its stock listing to the Nasdaq. Community discussion centers on the firm's commercial momentum, potential for long-term enterprise adoption, and its positioning within the broader quantum computing sector amid a period of high-beta market volatility.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing intense downward pressure as investors grow increasingly concerned about its valuation, the imminent expiration of insider lock-up periods, and significant dilution risks. The community is deeply divided, with vocal bears highlighting the lack of profitability and unsustainable IPO pricing, while long-term supporters continue to debate the stock's future potential and fair entry points.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is surging as escalating geopolitical tensions in the Middle East, particularly around critical shipping straits, trigger significant concerns over global supply disruptions. Investors are actively debating the potential for long-term oil price spikes, with many monitoring the impact of stalled diplomatic efforts and the ongoing volatility on energy markets.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing intense downward pressure and recent share price weakness following J&J's announcement of new clinical data for a combo therapy that potentially competes with Carvykti. The community is actively debating the company's valuation, questioning if this serves as a prime buyout opportunity or if the stock is struggling due to competitive threats and lack of leadership transparency.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is currently in the spotlight as investors react to a shift in capital strategy, where the company has notably slowed its Ethereum acquisitions to prioritize a multi-million share buyback program. While some in the community see this as a necessary move to support shareholder value and address the discount to net asset value, others remain deeply skeptical, expressing frustration over historical dilution and the divergence between the stock's price performance and Ethereum's underlying market moves.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALAI +13% since I recommended. Please sell after a 25% advance. I&#39;m done for today! I will go swimming, spa, and have fun with blondies. Have a good afternoon, gentlemen $SPY. @mhparvez @sonicmerlin @blancoBull @TaoistTrader @bsnacks @SonGoku

Goku

$ALAI this is a good buy for a very large portfolio.

StockTwits for iOS

Alger AI Enablers & Adopters ETF

TheArtOfFinancialWar

StockTwits Web

 +13% since I recommended. Please sell after a 25% advance. I'm done for today! I will go swimming, spa, and have fun with blondies. Have a good afternoon, gentlemen 